Where does Fujifilm Toyama Chemical Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Fujifilm Toyama Chemical Co., Ltd. ranks #7,844 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Fujifilm Toyama Chemical Co., Ltd. hold?

Fujifilm Toyama Chemical Co., Ltd. holds 41 US utility patents granted between 2019 and 2024, spanning 24 technology areas.

What is Fujifilm Toyama Chemical Co., Ltd.'s Innovation Score?

Fujifilm Toyama Chemical Co., Ltd. has an Innovation Score of 45.0 out of 100 (top 24% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Fujifilm Toyama Chemical Co., Ltd. focus on?

Fujifilm Toyama Chemical Co., Ltd.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 15 patents, ranking #1,291 of 6,058 assignees active in that subclass. Grants appear in 24 CPC subclasses total.

Is Fujifilm Toyama Chemical Co., Ltd.'s patent grant rate increasing or decreasing?

Fujifilm Toyama Chemical Co., Ltd.'s recent grant velocity is +483% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Fujifilm Toyama Chemical Co., Ltd.'s patents?

Fujifilm Toyama Chemical Co., Ltd.'s patents average 11.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Fujifilm Toyama Chemical Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Fujifilm Toyama Chemical Co., Ltd.

USPTO PatentsView assignee record - 41 granted patents across 24 technology areas, recorded in grant years 2019–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Fujifilm ranks #7,844 of 49,997 tracked US assignees by granted-patent volume, with 41 patents across 24 technology areas.

#7,844
of 49,997 US assignees by volume: Top 24%
by Innovation Score (45.0/100): 11.8
avg claims per patent: +483%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7844 · Foreign Corporation #7,844 · 41 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 41 grants
UPPER-Q #7,844/49,997
PHOTO-FINISH Element Biosciences
CPC-FOCUS A61P · 24 areas
INNOV-PAR 45.0/100
CLAIMS-PAR 11.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +483% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Element Biosciences, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Fujifilm’s 45.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.9 pts (29%) Velocity 7.7 pts (17%) Breadth 17.3 pts (38%) Claim depth 7.1 pts (16%)

Qualcomm Incorporated · highest

85
Fujifilm Toyama… · this assignee

45
Grass Valley · near

45
Mallinckrodt… · near

45
Timotion Technology · near

45
Weinberg Medical… · near

45
3D Lighting… · lowest

7

What this shows Fujifilm's Innovation Score is 45.0/100 (top 24% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Fujifilm?

Each dot is one of Fujifilm’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Fujifilm’s own 11.8 claims/patent is at or below the 14.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Fujifilm vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Fujifilm's grants concentrate

Fujifilm Toyama Chemical Co., Ltd. is a focused PatentsView assignee: 24 CPC subclasses with 36.6% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2022 (10 grants) versus a trough of 2 in 2024. By volume, Fujifilm sits between Element Biosciences, Inc. and GE Oil & Gas ESP, Inc..

Fujifilm's three-year grant acceleration

Fujifilm Toyama Chemical Co., Ltd. shows 22 grants in 2022–2024 against only 19 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Element Bioscienc…

41
Exact Sciences De…

41
Fine M-tec

41
Formosa Epitaxy I…

41
Ferric

41
Foret Plasma Labs

41
Fotonation Cayman

41
GE Oil & Gas ESP

41
Fujifilm Toyama C… ◀

41

What this shows Fujifilm holds 41 patents at rank #7,841, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Fujifilm

By rank, the assignees closest to #7,841 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Fujifilm's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Fujifilm, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Fujifilm ranks #1,291 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (45 here).

Weinberg Medical Physics, Inc 45 Grass Valley Limited 45 Mallinckrodt Hospital Products IP Unlimited Company 45 Timotion Technology Co., Ltd. 45

Fujifilm's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 24% higher than 76% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Fujifilm Toyama Chemical Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	6	14.6%
2020	7	17.1%
2021	6	14.6%
2022	10	24.4%
2023	10	24.4%
2024	2	4.9%

Which technologies does Fujifilm Toyama Chemical Co., Ltd. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 15

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 15

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 15

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 15

G06T - Image Data Processing OR Generation, IN General 12

G06V - Image OR Video Recognition OR Understanding 11

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 8

C07D - Heterocyclic Compounds 7

G06F - Electric Digital Data Processing 6

H04N - Pictorial Communication, e.g. Television 4

F25D - REFRIGERATORS; Cold ROOMS; ICE-BOXES; Cooling OR Freezing Apparatus NOT Otherwise Provided FOR 3

F25B - Refrigeration Machines, Plants OR SYSTEMS; Combined Heating AND Refrigeration SYSTEMS; Heat Pump Systems 3

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 3

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 2

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 2

Top 15 of 24 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Fujifilm Toyama Chemical Co., Ltd.'s patent record in context - here's where to go next.

Fujifilm Toyama Chemical Co., Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 36.6% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #7,844 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Fujifilm Toyama Chemical Co., Ltd. against Element Biosciences, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 45.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.